Showing 4291-4300 of 19393 results for "".
Detecting Parathyroid Disease
https://reachmd.com/programs/clinicians-roundtable/detecting-parathyroid-disease/3078/There are many new techniques to evaluate patients with thyroid and parathyroid disease. Dr. Mira Milas, associate professor at the Institute of Surgery, Endocrinology and Metabolism Institute at Cleveland Clinic Lerner College of Medicine, speaks about the use of ultrasound in thyroid disease detecUnderstanding the Revenue Cycle of a Hospital
https://reachmd.com/programs/clinicians-roundtable/understanding-the-revenue-cycle-of-a-hospital/2966/Could further educating physicians on the revenue cycle of the hospital increase cash flow? Dr. Robert Wagner, chief medical officer of Accretive Health, suggests that applying six sigma principals to the financial aspects of medicine can greatly improve the bottom line. Physicians should have a vesHealth-Related Quality of Life: How and Why Should We Measure It?
https://reachmd.com/programs/clinicians-roundtable/health-related-quality-of-life-how-and-why-should-we-measure-it/2954/Dr. Melanie Calvert, a research fellow at the University of Birmingham, PhD biochemist, and quality of life researcher speaks with host, Dr. Gary Kohn on quality of life measurement; how it's currently conducted and implemented in the medical field, and its future potential.Hepatitis C Treatment: Grim Fiscal Prospects?
https://reachmd.com/programs/gi-insights/hepatitis-c-treatment-grim-fiscal-prospects/2947/We are developing increasingly effective therapies for patients with chronic hepatitis C, yet many physicians who treat a high volume of these patients are struggling to maintain economically viable strategies for providing care. Is treatment of hepatitis C becoming a money-losing proposition? Can aThe Challenges of Caring for Patients with Hepatitis C
https://reachmd.com/programs/gi-insights/the-challenges-of-caring-for-patients-with-hepatitis-c/2946/The number of new cases of hepatitis C has declined significantly since its peak in the late 1980s. But now, two decades later, we’re seeing the manifestation of long-term complications from this chronic disease. Dr. Imtiaz Alam, founding medical director of the Austin Hepatitis Center in Austin, TeEducation, Research & NIH's Beleagured Budget
https://reachmd.com/programs/clinicians-roundtable/education-research-nihs-beleagured-budget/2943/The need for a sustained investment in medical research is critical to patient care. But annual budget cuts to the National Insitutes of Health have continued for years now. Dr. Darrell Kirch, president and CEO of the Association of American Medical Colleges tells the Chicago Tribune's Bruce JapsenPlanetree's Unique Model of Patient-Centered Care
https://reachmd.com/programs/clinicians-roundtable/panetrees-unique-model-of-patient-centered-care/2640/As the President of Planetree, Dr. Susan Frampton works with a growing network of hospitals and health center across the United States, Canada and Europe that have implemented Planetree's unique model of patient-centered care. Hear Dr. Frampton as she discusses how Planetree has grown over the lastThe Checklist
https://reachmd.com/programs/clinicians-roundtable/the-checklist/2628/His work has already saved more lives than any laboratory scientist in the past decade. Hear Dr. Peter J. Pronovost, Professor at Johns Hopkins University School of Medicine, as he discusses his internationally known patient safety checklists.Kenneth B. Schwartz: the Story of a Healthcare Pioneer
https://reachmd.com/programs/clinicians-roundtable/kenneth-b-schwartz-the-story-of-a-healthcare-pioneer/2620/During this segment hear Dr. Thomas Lynch, Professor of Medicine at Harvard Medical School, as he tells the inspirational the story of Kenneth B. Schwartz and his impact on the delivery of healthcare.Diuretics, Antihypertensives & Metabolic Syndrome
https://reachmd.com/programs/clinicians-roundtable/diuretics-antihypertensives-metabolic-syndrome/2596/Dr. Barry Davis, our guest, discusses with Dr. Larry Kaskel the results of the ALLHAT study which looked at antihypertensive drugs and diuretics and their impact on metabolic syndrome.